Pregnolia AG

Pregnolia has developed a measurement and diagnostic tool that helps doctors to significantly better assess the risk of premature birth. Up to 1 in 10 babies in developed countries are born too early, each costing USD 50’000 in hospital stays. Pregnolia’s patented technology doubles the rate of detection of mothers at risk of premature birth, as compared with the current gold standard procedure. The device measures the cervical tissue structure using a probe, producing a reading in seconds. With Pregnolia’s tool, obstetricians know better when to intervene to reduce the risk of early delivery.